Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome.
Zimmerhackl
Lothar Bernd
LB
Hofer
Johannes
J
Cortina
Gérard
G
Mark
Walter
W
Würzner
Reinhard
R
Jungraithmayr
Therese C
TC
Khursigara
Gus
G
Kliche
Kay O
KO
Radauer
Wolfgang
W
D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002648:Child; D003167:Complement Activation / Q000187:drug effects; D003176:Complement C3 / Q000378:metabolism; D017242:Complement Factor H / Q000235:genetics; D051056:Complement Inactivating Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006085:Graft Survival / Q000187:drug effects*; D006463:Hemolytic-Uremic Syndrome / Q000188:drug therapy / Q000601:surgery*; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D009154:Mutation; D055502:Secondary Prevention
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D003176:Complement C3; D051056:Complement Inactivating Agents; D017242:Complement Factor H; C481642:eculizumab